Clinical Trial Update: CP009 SYNERGOSS PXX Observational

View source ↗

Summary

An observational clinical trial update for CP009 SYNERGOSS PXX in patients with edentulous mouths; the study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mouth Edentulous

Drugs mentioned

• SYNERGOSS PXX (CP009)

Snippet

Sponsor: Nobil Bio Ricerche srl | Conditions: Mouth, Edentulous | Status: UNKNOWN